This inventor holds 3 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1978-1982.
Location History:
- Tokushima, JA (1978)
- Tokushima, JP (1980 - 1982)
Company Filing History:
Years Active: 1978-1982
Title: Kimiaki Oka: Innovator in Platelet Aggregation Inhibition
Introduction
Kimiaki Oka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit platelet aggregation. His work has implications for various medical conditions, including cardiovascular diseases.
Latest Patents
Kimiaki Oka holds 3 patents related to his innovative research. His latest patents focus on platelet aggregation inhibiting 2-oxyindoles and their derivatives. These compounds are represented by specific general formulas that detail the chemical structures and functional groups involved. The 2-oxyindole derivatives exhibit excellent effects on the inhibition of platelet aggregation, showcasing their potential therapeutic benefits.
Career Highlights
Oka is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research. His work at Otsuka has allowed him to explore the practical applications of his inventions in the pharmaceutical industry. His contributions have been instrumental in developing new treatments that can improve patient outcomes.
Collaborations
Throughout his career, Kimiaki Oka has collaborated with esteemed colleagues, including Minoru Uchida and Kamuyuki Nakagawa. These collaborations have fostered a productive research environment, leading to innovative solutions in the field of medicine.
Conclusion
Kimiaki Oka's work in the development of platelet aggregation inhibitors represents a significant advancement in medicinal chemistry. His patents and ongoing research continue to contribute to the understanding and treatment of cardiovascular diseases.